SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
171LPAAT-beta, A New Cancer Drug Development Target, Has Potential Use In Myeloid AThai Chung-12/9/2003
170TRISENOX(R)-ATRA Therapy Produces High Complete Remission Rates in Patients WithIcebrg-12/9/2003
169Pixantrone Induces Impressive 77% Major Tumor Response Rate in Patients With RelIcebrg-12/9/2003
168>>The short portfolio has closed its position in CTIC for a minor profit. Icebrg-12/8/2003
167>>SAN DIEGO, Dec. 8 /PRNewswire-FirstCall/ -- In four presentations at thetuck-12/8/2003
166Tom As long as the IP situation has not been settled Trisenox is in no-mans lanIcebrg-12/7/2003
165Any comments, Erik? Press Release Source: Cell Therapeutics, Inc. TRISENOX(R)tom pope-12/7/2003
164Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocuIcebrg-12/4/2003
163Study Reveals No Increase in Anthracycline-Induced Heart Damage With Pixantrone Icebrg-11/19/2003
162The company has filed a transcript of the recent presentation at CSFB with SEC. Icebrg-11/18/2003
161[2369] A Phase I Study of Pixantrone (BBR 2778) in Combination with CyclophosphaIcebrg-11/10/2003
160Impressive data for Pixantrone in the CHOP-Variant Regimen to Be Presented At thIcebrg-11/10/2003
159DRUG MAY TREAT PREVIOUSLY INCURABLE BRAIN CANCER, SAY STANFORD RESEARCHERS STANIcebrg-10/23/2003
158Transcript of a presentation given by Cell Therapeutics, Inc. on October 21, 200Icebrg-10/23/2003
157Novuspharma Commences a Phase II Study for Pixantrone in the New BSHAP Regimen WIcebrg-10/22/2003
156"An extraordinary Novuspharma Shareholders Meeting has been convocated in fIcebrg-9/29/2003
155The abstracts are available at: ex2.excerptamedica.comIcebrg-9/24/2003
154Poor timing by the WSJ, in the light of today's announcement (see the boldedtom pope-9/24/2003
15307:22 ET CTIC Cell Therapeutics has positive catalysts, buy-sideer sees $30 itom pope-9/19/2003
152This reaction is weird, down over 20% on the the acquisition news combined with tom pope-6/17/2003
151I guess they decided this was as good a day as any to trash the stock. It's tom pope-6/17/2003
150there's also this today: Reuters UPDATE - Cell Therapeutics lung cancer dtom pope-6/16/2003
149Investor Peter Angelos Has 5% Stake In Cell Therapeutics DOW JONES NEWSWIRES Wmopgcw-6/16/2003
148I would say "Ok, everybody leave!" but I'm not sure that's thecaly-6/6/2003
147Things were better when you were the only attendee...tom pope-6/6/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News